Marfan Syndrome
Marfan syndrome is an autosomal dominant, multisystem disorder of connective tissue that affects roughly 1 in 5,000 people. It is caused by heterozygous mutations in the FBN1 gene (chromosome 15q21.1), which encodes the protein fibrillin-1. When fibrillin-1 is deficient or structurally abnormal, the microfibril network of the extracellular matrix loses its mechanical integrity, and transforming growth factor beta (TGF-beta) signaling becomes excessively activated. The result is widespread tissue degeneration that seriously affects the heart and blood vessels, the skeleton and joints, and the eyes, and that shows up clearly as structural changes in the skin.
At Haute-Derma, recognizing the Marfan phenotype early is central to conservative aesthetic medicine. We do more than treat visible skin concerns such as deep, extensive stretch marks: before recommending any procedure, we carefully screen for underlying cardiovascular risk so that every treatment is as safe as possible.
Our Specialist Approach to Managing Marfan Syndrome
For patients with Marfan syndrome, every medical aesthetic intervention at Haute-Derma is built around protecting connective tissue that is already lax and fragile:
- Limiting breakdown of the extracellular matrix: We favor biological therapies that gently stimulate the body's own matrix production, helping to make up for the deficient microfibril network without triggering excessive inflammation.
- Prioritizing hemodynamic safety: For patients with known or suspected aortic root dilation, every treatment is planned to keep physical and emotional stress low and to avoid sudden rises in pressure on the vessel wall.
- Personalized treatment of stretch marks (striae distensae): We use non-ablative wavelengths to restore skin elasticity and keep strong chemical peels and deeply invasive lasers to a minimum, since these can injure an already very thin dermis.
Screening and Diagnosis Using the Revised Ghent Criteria at Haute-Derma
To confirm Marfan syndrome and distinguish it from other connective tissue disorders, Haute-Derma carries out a full clinical assessment based on the revised Ghent nosology:
- Systemic score (skeletal features): We examine and score characteristic findings, including:
- Steinberg (thumb) sign: with the fist closed, the thumb projects beyond the ulnar border of the hand.
- Walker–Murdoch (wrist) sign: the thumb and little finger overlap when wrapped around the opposite wrist.
- Chest wall deformity (sunken chest, pectus excavatum, or pigeon chest, pectus carinatum).
- An arm span-to-height ratio above 1.05, and reduced elbow extension.
- Skin and soft tissue findings: We ask about widespread stretch marks (striae atrophicae) in unusual places such as the shoulders, back, and thighs, appearing from puberty without major weight change or pregnancy, and we check for recurrent hernias.
- Regular Doppler echocardiography: To measure the aortic root diameter (expressed as a Z-score adjusted for age and body surface area) and to look for mitral valve prolapse.
- Molecular genetic testing: Sequencing of the FBN1 gene detects point mutations, frameshift mutations, and deletions, providing the most definitive diagnostic evidence.
Specialized Treatment and Skin Structure Restoration at Haute-Derma
Our treatment strategy aims to improve the appearance of the skin while protecting the cardiovascular and musculoskeletal systems:
- Pulsed dye laser (PDL): For early Marfan stretch marks (striae rubra, the red stage), we use a 595 nm PDL that targets hemoglobin in dilated small vessels. This reduces redness and inflammation and stimulates fibroblasts to produce type I collagen to fill in the damaged structure.
- Non-ablative fractional laser (1550 nm/1565 nm): For mature stretch marks (striae alba, the white stage), non-ablative lasers create microthermal treatment zones (MTZs) deep in the dermis while leaving the epidermis intact. This triggers the skin's own repair process, remodeling collagen and elastin around the defective fibrillin microfibrils and visibly softening the marks, with a very low risk of ulceration or skin infection.
- Angiotensin receptor blockers (ARBs) and medical protection: We work closely with cardiologists to monitor medications such as losartan, which dampens excess TGF-β signaling and slows aortic dilation, and we advise patients on exercise that avoids risky isometric (static straining) movements.
